Company Description
Ocean Biomedical, Inc., a biopharmaceutical company, focuses on discovering and developing therapeutic products in oncology, fibrosis, infectious diseases, and inflammation.
The company is developing mono-specific and bi-specific humanized monoclonal antibodies (mAb) product candidates targeting Chi3l1 for the treatment of non-small cell lung cancer and glioblastoma multiforme; and a small molecule product candidate targeting Chit1 for the treatment of Idiopathic Pulmonary Fibrosis and Hermansky-Pudlak Syndrome.
It is also developing three product candidates based on the WPDS platform, including a malaria vaccine candidate; a humanized mAb malaria therapeutic candidate targeting Plasmodium falciparum glutamic-acid-rich protein (PfGARP); and a small molecule malaria therapeutic candidate targeting PfGARP, as well as a product candidate for the treatment of COVID-19 in hospitalized patients.
The company was incorporated in 2019 and is based in Providence, Rhode Island.
| Country | United States |
| IPO Date | Nov 8, 2021 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 9 |
| CEO | Dr. M. Michelle Berrey M.D., M.P.H. |
Contact Details
Address: Room 325, 55 Claverick Street Providence, Rhode Island United States | |
| Website | http://www.oceanbiomedical.com |
Stock Details
| Ticker Symbol | OCEA |
| Exchange | NASDAQ |
| Fiscal Year | n/a |
| Reporting Currency | USD |
| CIK Code | 0001836612 |
| CUSIP Number | 67644P105 |
| ISIN Number | US67644C1045 |
| Employer ID | 85-4177213 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Dr. M. Michelle Berrey M.D., M.P.H. | Interim Chief Executive Officer & Director |
| Jolie G. Kahn CPA, Esq. | Chief Financial Officer |
| Dr. Chirinjeev Baboo Kathuria M.B.A., M.D. | Founder & Executive Chairman of the Board |
| Dr. Inderjote Kathuria M.B.A., M.D. | Chief Strategy Officer |
| Dr. Jack A. Elias M.D. | Founder, Chairman of Scientific Advisory Board & Independent Director |
| Dr. Jonathan Kurtis M.D., Ph.D. | Founder, Chairman of Scientific Advisory Board & Director |
| Robert John Sweeney | Chief Accounting Officer & Assistant Secretary |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Feb 16, 2023 | 3 | Filing |
| Feb 16, 2023 | RW | Filing |
| Apr 11, 2022 | S-1/A | [Amend] Filing |
| Feb 14, 2022 | S-1/A | [Amend] Filing |
| Feb 04, 2022 | S-1/A | [Amend] Filing |
| Jul 26, 2021 | S-1/A | [Amend] Filing |
| Jul 22, 2021 | CERT | Filing |
| Jul 20, 2021 | 8-A12B | Filing |
| Jul 20, 2021 | S-1/A | [Amend] Filing |
| Jul 14, 2021 | S-1/A | [Amend] Filing |